Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$1,034.23 10.14 (0.99%) as of 4:30 Fri 7/5


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 108.27(B)
Last Volume: 418,302 Avg Vol: 758,271
52 Week Range: $692.45 - $1071.19
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 192,995 237,237 312,646 469,880
Total Sell Value $189,656,342 $231,855,596 $295,997,978 $406,115,303
Total People Sold 7 13 16 18
Total Sell Transactions 18 40 67 129
End Date 2024-04-07 2024-01-05 2023-07-07 2022-07-07

   
Records found: 2433
  Page 72 of 98  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mccorkle Douglas S VP Controller and Asst Treasur   •       –      –    2012-02-15 4 S $111.08 $1,010,495 D/D (9,097) 5,353     -
   Stahl Neil SVP Research and Development S   •       –      –    2012-02-15 4 S $107.79 $2,273,036 D/D (21,082) 59,121     -
   Gilman Alfred G Director   –       •      –    2012-02-15 4 S $109.56 $2,928,977 D/D (26,734) 0     -
   Mccorkle Douglas S VP Controller and Asst Treasur   •       –      –    2012-02-14 4 D $111.01 $1,774,828 D/D (15,988) 14,450     -
   Mccorkle Douglas S VP Controller and Asst Treasur   •       –      –    2012-02-14 4 OE $16.80 $690,400 D/D 35,000 22,583     -
   Mccorkle Douglas S VP Controller and Asst Treasur   •       –      –    2012-02-14 4 S $109.01 $498,049 D/D (4,562) 0     -
   Goldstein Joseph L Director   –       •      –    2012-02-14 4 AS $110.02 $1,650,300 D/D (15,000) 0     -
   Goldstein Joseph L Director   –       •      –    2012-02-14 4 OE $24.41 $411,200 D/D 15,000 10,000     -
   Stahl Neil SVP Research and Development S   •       –      –    2012-02-14 4 S $107.83 $3,436,651 D/D (31,202) 80,203     -
   Stahl Neil SVP Research and Development S   •       –      –    2012-02-14 4 D $111.01 $3,210,187 D/D (28,918) 111,405     -
   Stahl Neil SVP Research and Development S   •       –      –    2012-02-14 4 OE $16.80 $840,000 D/D 50,000 140,323     -
   Gilman Alfred G Director   –       •      –    2012-02-14 4 D $111.01 $362,559 D/D (3,266) 26,734     -
   Gilman Alfred G Director   –       •      –    2012-02-14 4 OE $9.17 $362,700 D/D 30,000 27,972     -
   Stahl Neil SVP Research and Development S   •       –      –    2012-02-13 4 D $113.35 $4,019,844 D/D (35,464) 90,323     -
   Stahl Neil SVP Research and Development S   •       –      –    2012-02-13 4 OE $8.50 $566,661 D/D 66,666 92,177     -
   Goldberg Murray A SVP Finance and Admin CFO Trea   •       –      –    2012-02-07 4 AS $99.67 $1,747,866 D/D (17,500) 87,111     -
   Goldberg Murray A SVP Finance and Admin CFO Trea   •       –      –    2012-02-06 4 D $98.23 $2,299,859 D/D (23,413) 104,611     -
   Goldberg Murray A SVP Finance and Admin CFO Trea   •       –      –    2012-02-06 4 OE $16.80 $832,128 D/D 40,913 112,247     -
   Goldberg Murray A SVP Finance and Admin CFO Trea   •       –      –    2012-01-20 4 AS $77.86 $1,339,525 D/D (17,183) 89,361     -
   Goldberg Murray A SVP Finance and Admin CFO Trea   •       –      –    2012-01-19 4 D $79.53 $1,878,260 D/D (23,617) 106,544     -
   Goldberg Murray A SVP Finance and Admin CFO Trea   •       –      –    2012-01-19 4 OE $20.32 $829,056 D/D 40,800 130,161     -
   Goldstein Joseph L Director   –       •      –    2012-01-19 4 AS $80.00 $800,000 D/D (10,000) 0     -
   Vagelos P Roy Chairman of the Board   •       •      –    2012-01-12 4 GD $0.00 $0 I/I 3,786 167,761     -
   Terifay Robert J SVP Commercial   •       –      –    2012-01-11 4 AS $74.20 $669,210 D/D (9,019) 9,372     -
   Roberts William VP Regulatory Development and   •       –      –    2012-01-11 4 AS $73.99 $1,681,882 D/D (22,148) 61,144     -
  2433 Records found
  Previous  70  71  72  73  74  75  76  77  78  79  Next   
  Page 72 of 98
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us